BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance MENLO PARK, CA, May 6, 2026 - BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the first quarter ended March 31, 2026 and raised guidance for full year 2026. Financial Highlights: Recent Operating Highlights: ● In May, we announced the launch of Unity Confirm , a circulating ...